514 related articles for article (PubMed ID: 30101710)
21. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
Helboe L; Egebjerg J; Barkholt P; Volbracht C
Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
[TBL] [Abstract][Full Text] [Related]
22. EFhd2 is a novel amyloid protein associated with pathological tau in Alzheimer's disease.
Ferrer-Acosta Y; Rodríguez-Cruz EN; Orange F; De Jesús-Cortés H; Madera B; Vaquer-Alicea J; Ballester J; Guinel MJ; Bloom GS; Vega IE
J Neurochem; 2013 Jun; 125(6):921-31. PubMed ID: 23331044
[TBL] [Abstract][Full Text] [Related]
23. Study of tau pathology in male rTg4510 mice fed with a curcumin derivative Shiga-Y5.
Yanagisawa D; Hamezah HS; Durani LW; Taguchi H; Tooyama I
PLoS One; 2018; 13(12):e0208440. PubMed ID: 30521594
[TBL] [Abstract][Full Text] [Related]
24. Targeting tauopathy with engineered tau-degrading intrabodies.
Gallardo G; Wong CH; Ricardez SM; Mann CN; Lin KH; Leyns CEG; Jiang H; Holtzman DM
Mol Neurodegener; 2019 Oct; 14(1):38. PubMed ID: 31640765
[TBL] [Abstract][Full Text] [Related]
25. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease.
Chiasseu M; Alarcon-Martinez L; Belforte N; Quintero H; Dotigny F; Destroismaisons L; Vande Velde C; Panayi F; Louis C; Di Polo A
Mol Neurodegener; 2017 Aug; 12(1):58. PubMed ID: 28774322
[TBL] [Abstract][Full Text] [Related]
26. SPOP loss of function protects against tauopathy.
Eck RJ; Kow RL; Black AH; Liachko NF; Kraemer BC
Proc Natl Acad Sci U S A; 2023 Jan; 120(1):e2207250120. PubMed ID: 36574656
[TBL] [Abstract][Full Text] [Related]
27. Activity of the poly(A) binding protein MSUT2 determines susceptibility to pathological tau in the mammalian brain.
Wheeler JM; McMillan P; Strovas TJ; Liachko NF; Amlie-Wolf A; Kow RL; Klein RL; Szot P; Robinson L; Guthrie C; Saxton A; Kanaan NM; Raskind M; Peskind E; Trojanowski JQ; Lee VMY; Wang LS; Keene CD; Bird T; Schellenberg GD; Kraemer B
Sci Transl Med; 2019 Dec; 11(523):. PubMed ID: 31852801
[TBL] [Abstract][Full Text] [Related]
28. Tauopathy induced by low level expression of a human brain-derived tau fragment in mice is rescued by phenylbutyrate.
Bondulich MK; Guo T; Meehan C; Manion J; Rodriguez Martin T; Mitchell JC; Hortobagyi T; Yankova N; Stygelbout V; Brion JP; Noble W; Hanger DP
Brain; 2016 Aug; 139(Pt 8):2290-306. PubMed ID: 27297240
[TBL] [Abstract][Full Text] [Related]
29. Accelerated neurodegeneration and neuroinflammation in transgenic mice expressing P301L tau mutant and tau-tubulin kinase 1.
Asai H; Ikezu S; Woodbury ME; Yonemoto GM; Cui L; Ikezu T
Am J Pathol; 2014 Mar; 184(3):808-18. PubMed ID: 24418258
[TBL] [Abstract][Full Text] [Related]
30. Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy.
Koller EJ; Gonzalez De La Cruz E; Machula T; Ibanez KR; Lin WL; Williams T; Riffe CJ; Ryu D; Strang KH; Liu X; Janus C; Golde TE; Dickson D; Giasson BI; Chakrabarty P
Hum Mol Genet; 2019 Oct; 28(19):3255-3269. PubMed ID: 31261380
[TBL] [Abstract][Full Text] [Related]
31. Proteomic profiling of brain cortex tissues in a Tau transgenic mouse model of Alzheimer's disease.
Chang SH; Jung IS; Han GY; Kim NH; Kim HJ; Kim CW
Biochem Biophys Res Commun; 2013 Jan; 430(2):670-5. PubMed ID: 23211594
[TBL] [Abstract][Full Text] [Related]
32. Arterial spin labeling demonstrates preserved regional cerebral blood flow in the P301L mouse model of tauopathy.
Kindler D; Maschio C; Ni R; Zerbi V; Razansky D; Klohs J
J Cereb Blood Flow Metab; 2022 Apr; 42(4):686-693. PubMed ID: 34822744
[TBL] [Abstract][Full Text] [Related]
33. Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model.
Shimojo M; Takuwa H; Takado Y; Tokunaga M; Tsukamoto S; Minatohara K; Ono M; Seki C; Maeda J; Urushihata T; Minamihisamatsu T; Aoki I; Kawamura K; Zhang MR; Suhara T; Sahara N; Higuchi M
J Neurosci; 2020 Apr; 40(17):3491-3501. PubMed ID: 32265258
[TBL] [Abstract][Full Text] [Related]
34. P-tau217 correlates with neurodegeneration in Alzheimer's disease, and targeting p-tau217 with immunotherapy ameliorates murine tauopathy.
Zhang D; Zhang W; Ming C; Gao X; Yuan H; Lin X; Mao X; Wang C; Guo X; Du Y; Shao L; Yang R; Lin Z; Wu X; Huang TY; Wang Z; Zhang YW; Xu H; Zhao Y
Neuron; 2024 May; 112(10):1676-1693.e12. PubMed ID: 38513667
[TBL] [Abstract][Full Text] [Related]
35. Broad Kinase Inhibition Mitigates Early Neuronal Dysfunction in Tauopathy.
Koren SA; Hamm MJ; Cloyd R; Fontaine SN; Chishti E; Lanzillotta C; Rodriguez-Rivera J; Ingram A; Bell M; Galvis-Escobar SM; Zulia N; Di Domenico F; Duong D; Seyfried NT; Powell D; Vandsburger M; Frolinger T; Hartz AMS; Koren J; Axten JM; Laping NJ; Abisambra JF
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530349
[TBL] [Abstract][Full Text] [Related]
36. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
[TBL] [Abstract][Full Text] [Related]
37. N-terminal tau truncation in the pathogenesis of Alzheimer's disease (AD): Developing a novel diagnostic and therapeutic approach.
Amadoro G; Latina V; Corsetti V; Calissano P
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165584. PubMed ID: 31676377
[TBL] [Abstract][Full Text] [Related]
38. A rapid gene delivery-based mouse model for early-stage Alzheimer disease-type tauopathy.
Siman R; Lin YG; Malthankar-Phatak G; Dong Y
J Neuropathol Exp Neurol; 2013 Nov; 72(11):1062-71. PubMed ID: 24128676
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylated p38MAPK specific antibodies cross-react with sarkosyl-insoluble hyperphosphorylated tau proteins.
Sahara N; Vega IE; Ishizawa T; Lewis J; McGowan E; Hutton M; Dickson D; Yen SH
J Neurochem; 2004 Aug; 90(4):829-38. PubMed ID: 15287888
[TBL] [Abstract][Full Text] [Related]
40. Age-related impairment of ultrasonic vocalization in Tau.P301L mice: possible implication for progressive language disorders.
Menuet C; Cazals Y; Gestreau C; Borghgraef P; Gielis L; Dutschmann M; Van Leuven F; Hilaire G
PLoS One; 2011; 6(10):e25770. PubMed ID: 22022446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
